MAP Study: Methotrexate and Adalimumab in Psoriasis
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
Assess the efficacy and safety of ADA compared to ADA/MTX in patient with Psoriasis. Compare
Anti-ADA antibody formation and serum ADA levels in patients on ADA compared with those on
combination ADA and MTX.